Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Inflammation, Oxidative Stress and L-Fucose as Indispensable Participants in Schistosomiasis-Associated Colonic Dysplasia

  • Published : 2014.02.01
Download PDF
⟨ Previous Next ⟩

Abstract

Background: Schistosomiasis is a parasitic disease causing chronic ill health in humans with a serious consequences for socio-economic development in tropical and subtropical regions. There is also evidence linking Schistosoma mansoni to colonic carcinoma occurrence. The aim of this study was to evaluate some inflammatory and oxidative stress biomarkers, as well as L-fucose as linkers between intestinal schistosomiasis and colonic dysplasia development in mice. Materials and Methods: This study was conducted upon 80 mice that were divided the control group (10 non infected mice) and infected group which was subdivided into 7 sub-groups (10 mice each) according to the time of sacrifaction in the post infection (p.i.) period, 10 mice being sacrificed every two weeks from 6 weeks p.i. to 18 weeks p.i. Tumor necrosis factor alpha (TNF-${\alpha}$), inducible nitric oxide synthase (iNOS), and pentraxin 3 (PTX3) levels were estimated by immunoassay. The L-fucose level, and thioredoxin reductase (TrxR) and lactate dehydrogenase (LDH) activities were also evaluated in colonic tissue. Results: The current study revealed statistically significant elevation in the studied biochemical markers especially at 16 and 18 weeks p.i. The results were confirmed by histopathological examination that revealed atypical architectural and cytological changes in the form of epithelial surface serration and nuclear hyper-chromatizia at 14, 16 and 18 weeks p.i. Conclusions: inflammation, oxidative stress and L-fucose together may form an important link between Schistosomal mansoni infection and colonic dysplasia and they can be new tools for prediction of colonic dysplasia development in experimental schistosomiasis.

Keywords

References

  1. Abdul-Ghani RA, Hassan AA (2010). Murine schistosomiasis as a model for human schistosomiasis mansoni: similarities and discrepancies. Parasitol Res, 107, 1-8. https://doi.org/10.1007/s00436-010-1855-5
  2. Ahmed SA, Gad MZ (1995). Effect of schistosomal infection and its treatment on some key enzymes of glucose metabolism in mice livers. Arzneimittelforschung, 45, 1324-8.
  3. Aly HF, Hamed MA, Ahmed SA, et al (2004). Selected some biochemical parameters used as new markers for diagnosis of bladder cancer. Egypt J Schistosomiasis Infect Endem Dis, 26, 41-63.
  4. Arner ES, Holmgren A (2000). Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem, 267, 6102-9. https://doi.org/10.1046/j.1432-1327.2000.01701.x
  5. Babson AL, Babson SR (1973). Kinetic colorimetric measurement of serum lactate dehydrogenase activity. Clin Chem, 19, 766-9.
  6. Balkwill F (2009). Tumour necrosis factor and cancer. Nat Rev Cancer, 9, 361-71. https://doi.org/10.1038/nrc2628
  7. Biaglow JE, Miller RA (2005). The thioredoxin reductase/thioredoxin system: novel redox targets for cancer therapy. Cancer Biol Ther, 4, 6-13.
  8. Calatayud S, Barrachina D, Esplugues JV (2001). Nitric oxide: relation to integrity, injury, and healing of the gastric mucosa. Microsc Res Tech, 53, 325-35. https://doi.org/10.1002/jemt.1100
  9. Christersdottir Bjorklund T, Reilly SJ, Gahm C, et al (2013). Increased long-term expression of pentraxin 3 in irradiated human arteries and veins compared to internal controls from free tissue transfers. J Transl Med, 11, 223-33. https://doi.org/10.1186/1479-5876-11-223
  10. Cao J, Liu WJ, Xu XY, et al (2010). Endoscopic findings and clinicopathologic characteristics of colonic schistosomiasis: a report of 46 cases. World J Gastroenterol, 16, 723-7. https://doi.org/10.3748/wjg.v16.i6.723
  11. Diche Z (1949). Determination of serum protein bound and tissue homogenate L-fucose. J Biol Chem, 181, 379.
  12. Farid M, El-Awady S, Abdel-Moneim H, et al (2006). Evolution of colorectal cancer in schistosomiasis. Egypt J Surg, 25, 206-12.
  13. Fedewa SA, Soliman AS, Ismail K, et al (2009). Incidence analyses of bladder cancer in the Nile delta region of Egypt. Cancer Epidemiol, 33, 176-81. https://doi.org/10.1016/j.canep.2009.08.008
  14. Gryseels B, Polman K, Clerinx J, et al (2006). Human schistosomiasis. Lancet, 368, 1106-18. https://doi.org/10.1016/S0140-6736(06)69440-3
  15. H Salim OE, Hamid HK, Mekki SO, et al (2010). Colorectal carcinoma associated with schistosomiasis: a possible causal relationship. World J Surg Oncol, 13, 68-73.
  16. Hamed MA, Ahmed SA, Khaled HM (2011). Efficiency of diagnostic biomarkers among colonic schistosomiasis Egyptian patients. Mem Inst Oswaldo Cruz, 106, 322-9. https://doi.org/10.1590/S0074-02762011000300011
  17. Hamed MA, Ali HF, Ali SA, et al (2010). Biomphalaria alexandrina snails as immunogens against Schistosoma mansoni infection in mice. Mem Inst Oswaldo Cruz, 105, 879-88. https://doi.org/10.1590/S0074-02762010000700007
  18. Holmgren A, Bjornstedt M (1995). Thioredoxin and thioredoxin reductase. Methods Enzymol, 252, 199-208. https://doi.org/10.1016/0076-6879(95)52023-6
  19. Hope ME, Hold GL, Kain R, et al (2005). Sporadic colorectal cancer--role of the commensal microbiota. FEMS Microbiol Lett, 244, 1-7. https://doi.org/10.1016/j.femsle.2005.01.029
  20. Kossowska B, Ferens-Sieczkowska M, Gancarz R, et al (2005). Fucosylation of serum glycoproteins in lung cancer patients. Clin Chem Lab Med, 43, 361-9.
  21. Lewis FA, Stirewalt MA, Souza CP, et al (1986). Large- scale laboratory maintenance of Schistosoma mansoni, with observations on three schistosome snail host combination. J Parasitol, 772, 813-29.
  22. Lincoln DT, Ali Emadi EM, Tonissen KF, et al (2003). The thioredoxin-thioredoxin reductase system: over-expression in human cancer. Anticancer Res, 23, 2425-33.
  23. Lowry OH, Rosebrough NJ, Farr AL, et al (1951). Protein measurement with folin phenol reagent. J Biol Chem, 193, 265-75.
  24. Madbouly KM, Senagore AJ, Mukerjee A, et al (2007). Colorectal cancer in a population with endemic Schistosoma mansoni: is this an at-risk population? Int J Colorectal Dis, 22, 175-81.
  25. Manjula S, Monteiro F, Rao Aroor A, et al (2010). Assessment of serum L-fucose in brain tumor cases. Ann Indian Acad Neuro, 13, 33-6. https://doi.org/10.4103/0972-2327.61274
  26. Mantawy MM, Ali HF, Rizk MZ (2011). Therapeutic effects of Allium sativum and Allium cepa in Schistosoma mansoni experimental infection. Rev Inst Med Trop Sao Paulo, 53, 155-63. https://doi.org/10.1590/S0036-46652011000300007
  27. Medzhitov R (2008). Origin and physiological roles of inflammation. Nature, 454, 428-35. https://doi.org/10.1038/nature07201
  28. Metwally NS, Ali SA, Mohamed AM, et al (2011). Levels of certain tumor markers as differential factors between bilharzial and non-biharzial bladder cancer among Egyptian patients. Cancer Cell Int, 11, 8-18. https://doi.org/10.1186/1475-2867-11-8
  29. Mostafa MH, Sheweita SA, O'Connor PJ (1999). Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev, 12, 97-111.
  30. Mukherjee A, Martin SG (2008). The thioredoxin system: a key target in tumour and endothelial cells. Br J Radiol, 81, 57-68.
  31. Ohshima H, Sawa T, Akaike T (2006). Nitroguanine, a product of nitrative DNA damage caused by reactive nitrogen species: formation, occurrence, and implications in inflammation and carcinogenesis. Antioxid Redox Signal, 8, 1033-45. https://doi.org/10.1089/ars.2006.8.1033
  32. Okutani D (2006). The role of long pentraxin 3, a new inflammatory mediator in inflammatory responses. Nihon Rinsho Meneki Gakkai Kaishi, 29, 107-13. https://doi.org/10.2177/jsci.29.107
  33. Peters PA, Warren KS (1969). A rapid method for infecting mice and other laboratory animals with subcutaneous injection. J Parasitol, 131, 558-61.
  34. Ross AG, Bartley PB, Sleigh AC, et al (2002). Schistosomiasis. N Engl J Med, 346, 1212-20. https://doi.org/10.1056/NEJMra012396
  35. Salim EI, Morimura K, Menesi A, et al (2008). Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinomas associated with schistosomiasis. Int J Cancer, 123, 601-8. https://doi.org/10.1002/ijc.23547
  36. Salustri A, Garlanda C, Hirsch E, et al (2004). PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization. Development, 131, 1577-86. https://doi.org/10.1242/dev.01056
  37. Schetter AJ, Heegaard NH, Harris CC (2010). Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis, 31, 37-49. https://doi.org/10.1093/carcin/bgp272
  38. Shin YK, Yoo BC, Hong YS, et al (2009). Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance. Electrophoresis, 30, 2182-92. https://doi.org/10.1002/elps.200800806
  39. Smart DK, Ortiz KL, Mattson D, et al (2004). Thioredoxin reductase as a potential molecular target for anticancer agents that induce oxidative stress. Cancer Res, 64, 6716-24. https://doi.org/10.1158/0008-5472.CAN-03-3990
  40. Takeda Y, Shinzaki S, Okudo K, et al (2012). Fucosylated haptoglobin is a novel type of cancer biomarker linked to the prognosis after an operation in colorectal cancer. Cancer, 118, 3036-43. https://doi.org/10.1002/cncr.26490
  41. Talero E, Sanchez-Fidalgo S, Villegas I, et al (2011). Role of different inflammatory and tumor biomarkers in the development of ulcerative colitis-associated carcinogenesis. Inflamm Bowel Dis, 17, 696-710. https://doi.org/10.1002/ibd.21420
  42. Thangaraju M, Carswell KN, Prasad PD (2009). Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3. Biochem J, 417, 379-89. https://doi.org/10.1042/BJ20081132
  43. van Horssen R, Ten Hagen TL, Eggermont AM (2006). TNF-${\alpha}$ in cancer treatment: molecular insights, antitumor effects and clinical utility. The Oncologist, 11, 397-408. https://doi.org/10.1634/theoncologist.11-4-397
  44. Vettraino M, Manerba M, Govoni M, et al (2013). Galloflavin suppresses lactate dehydrogenase activity and causes MYC down regulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1. Anticancer Drugs, 24, 862-70. https://doi.org/10.1097/CAD.0b013e328363ae50
  45. Willeke F, Assad A, Findeisen P, et al (2005). Overexpression of a member of the pentraxin family (PTX3) in human soft tissue liposarcoma. Eur J Cancer, 42, 2639-46.
  46. Yan B, Wang H, Rabbani ZN, et al (2006). Tumor necrosis factor-${\alpha}$ is a potent endogenous mutagen that promotes cellular transformation. Cancer Res, 66, 11565-70. https://doi.org/10.1158/0008-5472.CAN-06-2540
  47. Yang GY, Taboada S, Liao J (2009). Induced nitric oxide synthase as a major player in the oncogenic transformation of inflamed tissue. Methods Mol Biol, 512, 119-56. https://doi.org/10.1007/978-1-60327-530-9_8
  48. Yang Y, Karakhanova S, Werner J (2013). Reactive oxygen species in cancer biology and anticancer therapy. Curr Med Chem, 20, 3677-92. https://doi.org/10.2174/0929867311320999165
  49. Yosry A (2006). Schistosomiasis and neoplasia. Contrib Microbiol, 13, 81-100.
  50. Yu JX, Cui L, Zhang QY, et al (2006). Expression of NOS and HIF-1alpha in human colorectal carcinoma and implication in tumor angiogenesis. World J Gastroenterol, 12, 4660-4.
  51. Zhang D, Ren WH, Gao Y, et al (2013).Clinical significance and prognostic value of pentraxin-3 as serologic biomarker for lung cancer. Asian Pac J Cancer Prev, 14, 4215-21. https://doi.org/10.7314/APJCP.2013.14.7.4215

Cited by

  1. Roles of Oxidative Stress in the Development and Progression of Breast Cancer vol.15, pp.12, 2014, https://doi.org/10.7314/APJCP.2014.15.12.4745
  2. Albumin-globulin Ratio for Prediction of Long-term Mortality in Lung Adenocarcinoma Patients vol.15, pp.15, 2014, https://doi.org/10.7314/APJCP.2014.15.15.6449
  3. Histopathological Profile of Benign Colorectal Diseases in Al-Madinah Region of Saudi Arabia vol.15, pp.18, 2014, https://doi.org/10.7314/APJCP.2014.15.18.7673
  4. Frontline Science: Plasma and immunoglobulin G galactosylation associate with HIV persistence during antiretroviral therapy vol.104, pp.3, 2018, https://doi.org/10.1002/JLB.3HI1217-500R